New York: 01:45 || London: 06:45 || Mumbai: 12:15 || Singapore: 14:45

News & Analysis » India

Ranbaxy Unit Sets Up New Manufacturing Facility In South Africa

September 1, 2010, Wednesday, 18:55 GMT | 13:55 EST | 23:25 IST | 01:55 SGT

(RTTNews) - Ranbaxy Laboratories Ltd. said its wholly owned subsidiary and Centurion-based Ranbaxy (S.A) (Pty.) Ltd. opened a new manufacturing facility by name Be-Tabs Pharmaceuticals Manufacturing Plant at Roodepoort, Johannesburg, South Africa, at an investment of $30 million.

The new facility was inaugurated on Wednesday by Anand Sharma, Minister for Commerce and Industry, Govt. of India, in the presence of the Indian High commissioner Virendra Gupta and representatives from the South African Department of Trade and Industry.

The new facility will manufacture analgesics, cold, cough and flu preparations, anti-histamines, anti-hypertensives, CNS drugs, vitamins and minerals as well as a comprehensive range of over-the-counter medication. The products manufactured will comprise tablets and hard gelatin capsules that will be supplied to current registered regions.

The plant is capable of producing around 1.75 billion units and packaging of 2.0 billion u nits, annually. Possible expansion could bring about the addition of new products, the company said.

At the BSE, Ranbaxy closed Wednesday's trading at Rs.497.75, up by Rs.7.50 or 1.53% on a volume of 139,000 shares. The stock touched an intraday high of Rs.499.35 and a low of Rs.490.